BEAUMONT HEALTH - TRENTON
1. Target Overview & Investment Thesis
BEAUMONT HEALTH - TRENTON is a 193-bed suburban community hospital in WAYNE, MI with $204.5M in net patient revenue and a 3.4% operating margin. The hospital serves a payer mix of 29.5% Medicare, 2.3% Medicaid, and 68.2% commercial.
Thesis: Undervalued. Our ML models identify $15.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.4% to 10.8% (+736bps).
| Net Revenue HCRIS | $204.5M |
| Current EBITDA COMPUTED | $7.1M |
| Operating Margin COMPUTED | 3.4% |
| Occupancy HCRIS | 61.5% |
| Revenue / Bed COMPUTED | $1.1M |
| Net-to-Gross HCRIS | 18.1% |
| Distress Probability ML | 44.3% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 3.4% places it above the state median. Among 54 size-comparable peers (96-386 beds), the median margin is -7.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (96-386), prioritizing same-state peers. 54 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BEAUMONT HEALTH - TRENTON (Target) | MI | 193 | $204.5M | 3.4% |
| W.A. FOOTE MEMORIAL HOSPITAL | MI | 331 | $681.8M | -9.0% |
| TRINITY HEALTH MUSKEGON | MI | 262 | $621.2M | -15.5% |
| TRINITY HEALTH GRAND RAPIDS | MI | 271 | $601.8M | -27.3% |
| HENRY FORD HEALTH MACOMB HOSPI | MI | 303 | $584.5M | -6.9% |
| MYMICHIGAN MEDICAL CENTER MIDL | MI | 195 | $537.8M | -9.6% |
| METROPOLITAN HOSPITAL | MI | 201 | $512.0M | -11.3% |
| LAKELAND MEDICAL CENTER ST. J | MI | 235 | $488.2M | -3.6% |
| TRINITY HEALTH OAKLAND | MI | 333 | $480.5M | -7.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $4.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $4.1M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $4.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $131K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $7.1M |
| + RCM Uplift | +$15.1M |
| Pro Forma EBITDA | $22.1M |
| Current Margin | 3.4% |
| Pro Forma Margin | 10.8% |
| WC Released (1x) | $7.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $10.8M | $197.0M | 18.16x | 78.6% |
| Base (11x exit) | 10.0x | 11.0x | $10.8M | $220.3M | 20.31x | 82.6% |
| Bull Case | 9.0x | 11.0x | $9.8M | $273.5M | 28.01x | 94.7% |
| Bull (12x exit) | 9.0x | 12.0x | $9.8M | $301.2M | 30.85x | 98.6% |
| Bear Case | 11.0x | 10.0x | $11.9M | $118.2M | 9.91x | 58.2% |
| Bear (11x exit) | 11.0x | 11.0x | $11.9M | $133.9M | 11.23x | 62.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 54 hospitals with 96-386 beds
- Same-state prioritization (n=55)
- Comp margins: P25=-13.6% / P50=-7.2% / P75=-0.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.